BCDA
BCDA
NASDAQ · Biotechnology

Biocardia Inc

$1.21
+0.05 (+4.31%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +2,706.6% upside
Low Target $19.62
Average Target $33.96
High Target $35.69
Current Price $1.21
Current
$1.21
Target
$33.96
$19.62 $33.96 avg $35.69
Scenario Analysis
Bear Case
$19.62
1,521.5%
Low target
Base Case
$33.96
+2,706.6%
Avg target
Bull Case
$35.69
+2,849.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.20
-62.2% from high
52-Week Low
$1.00
+21.0% from low
Target vs 52W High
$33.96
+961.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%